Oragenics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-37 | $7 |
Gross Profit | -906 | -663 | -11,079 | 2 |
EBITDA | -2,306 | -2,460 | -2,522 | -1,993 |
EBIT | -2,312 | -2,466 | -2,566 | -1,998 |
Net Income | -2,305 | -2,450 | -12,747 | -2,012 |
Net Change In Cash | 0 | 0 | -37 | 7 |
Free Cash Flow | -1,544 | -3,064 | -1,102 | -1,503 |
Cash | 1,348 | 2,071 | 3,483 | 5,766 |
Basic Shares | 4,529 | 3,496 | 3,080 | 2,356 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $37 | $131 | $86 | $0 |
Gross Profit | -15,452 | 86 | 45 | -51 |
EBITDA | -20,877 | -14,228 | -15,654 | -26,501 |
EBIT | -20,904 | -14,273 | -15,771 | -26,552 |
Net Income | -20,655 | -14,161 | -15,728 | -26,443 |
Net Change In Cash | 37 | 131 | 86 | 0 |
Cost of Revenue | -628 | |||
Free Cash Flow | -7,290 | -15,356 | -13,514 | -16,952 |
Cash | 3,483 | 11,426 | 27,265 | 17,639 |
Basic Shares | 2,249 | 2,009 | 1,881 | 942 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.50 |
2024-03-31 | -$0.70 |
2023-12-31 | -$4.13 |
2023-09-30 | -$0.85 |
